{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:29:02Z","timestamp":1778858942898,"version":"3.51.4"},"reference-count":157,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002397","name":"Shanghai University of Sport","doi-asserted-by":"publisher","award":["Shanghai Frontiers Science Research Base of Exercise and Metabolic Health"],"award-info":[{"award-number":["Shanghai Frontiers Science Research Base of Exercise and Metabolic Health"]}],"id":[{"id":"10.13039\/501100002397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejmech.2025.117906","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T10:56:41Z","timestamp":1750762601000},"page":"117906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Orphan GPCRs regulate the metabolic liver diseases through mediating the crosstalk between the liver and immune cells: Mechanisms and therapeutics"],"prefix":"10.1016","volume":"297","author":[{"given":"Yining","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117906_bib1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.ejmech.2025.117906_bib2","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1053\/j.gastro.2023.05.053","article-title":"Prevalence of liver steatosis and fibrosis in the general population and various high-risk populations: a nationwide study with 5.7 million adults in China","volume":"165","author":"Man","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejmech.2025.117906_bib3","first-page":"167","article-title":"Pathogenesis and prevention of hepatic steatosis","volume":"11","author":"Nassir","year":"2015","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2025.117906_bib4","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ejmech.2025.117906_bib5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41575-020-00408-y","article-title":"Therapeutic pipeline in nonalcoholic steatohepatitis","volume":"18","author":"Vuppalanchi","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2025.117906_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25073694","article-title":"Underlying mechanisms behind the brain-gut-liver axis and metabolic-associated fatty liver disease (MAFLD): an update","volume":"25","author":"De C\u00f3l","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117906_bib7","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144801","article-title":"Sparcl1 promotes nonalcoholic steatohepatitis progression in mice through upregulation of CCL2","volume":"131","author":"Liu","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2025.117906_bib8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","article-title":"Immune cell-mediated features of non-alcoholic steatohepatitis","volume":"22","author":"Huby","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2025.117906_bib9","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1038\/s41467-023-40183-3","article-title":"LILRB2\/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117906_bib10","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/hep.32782","article-title":"CD11b + CD43 hi Ly6C lo splenocyte-derived macrophages exacerbate liver fibrosis via spleen-liver axis","volume":"77","author":"Zhang","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2025.117906_bib11","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.117906_bib12","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000001254","article-title":"Comparison of pharmacological therapies in metabolic dysfunction-associated steatohepatitis for fibrosis regression and MASH resolution: systematic review and network meta-analysis","author":"Souza","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2025.117906_bib13","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa2304286","article-title":"Randomized, controlled trial of the FGF21 analogue pegozafermin in NASH","volume":"389","author":"Loomba","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.117906_bib14","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis","author":"Sanyal","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.117906_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tips.2011.09.003","article-title":"Diversity and modularity of G protein-coupled receptor structures","volume":"33","author":"Katritch","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2025.117906_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1021\/acs.chemrev.6b00177","article-title":"GPCR dynamics: structures in motion","volume":"117","author":"Latorraca","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.117906_bib17","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease","volume":"152","author":"Ch\u00e1vez-Talavera","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejmech.2025.117906_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104952","article-title":"Lactobacillus acidophilus suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma through producing valeric acid","volume":"100","author":"Lau","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejmech.2025.117906_bib19","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1006\/geno.1997.4754","article-title":"Isolation and chromosomal localization of GPR31, a human gene encoding a putative G protein-coupled receptor","volume":"42","author":"Zingoni","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.ejmech.2025.117906_bib20","article-title":"The dark sides of the GPCR tree - research progress on understudied GPCRs","author":"Scharf","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117906_bib21","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1172\/JCI85676","article-title":"Disruption of Gpr45 causes reduced hypothalamic POMC expression and obesity","volume":"126","author":"Cui","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2025.117906_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aab3492","article-title":"Loss of GPR3 reduces the amyloid plaque burden and improves memory in alzheimer's disease mouse models","volume":"7","author":"Huang","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2025.117906_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1172\/JCI131609","article-title":"GPR101 mediates the pro-resolving actions of RvD5n-3 DPA in arthritis and infections","volume":"130","author":"Flak","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2025.117906_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54681-5","article-title":"Molecular insights into the activation mechanism of GPR156 in maintaining auditory function","volume":"15","author":"Ma","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117906_bib25","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jhep.2023.07.005","article-title":"Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma","volume":"79","author":"Song","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejmech.2025.117906_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adg6453","article-title":"The acid-sensing receptor GPR65 on tumor macrophages drives tumor growth in obesity","volume":"9","author":"Bagchi","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.ejmech.2025.117906_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103403","article-title":"ZnR\/GPR39 regulates hepatic insulin signaling, tunes liver bioenergetics and ROS production, and mitigates liver fibrosis and injury","volume":"78","author":"Shendge","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2025.117906_bib28","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.32233","article-title":"Melatonin receptor 1A, but not 1B, knockout decreases biliary damage and liver fibrosis during cholestatic liver injury","volume":"75","author":"Wu","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2025.117906_bib29","first-page":"56","article-title":"Targeting GPR65 alleviates hepatic inflammation and fibrosis by suppressing the JNK and NF-\u03baB pathways","volume":"10","author":"Zhang","year":"2023","journal-title":"Mil Med. Res."},{"key":"10.1016\/j.ejmech.2025.117906_bib30","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1016\/j.cmet.2024.09.007","article-title":"Sensing steroid hormone 17\u03b1-hydroxypregnenolone by GPR56 enables protection from ferroptosis-induced liver injury","volume":"36","author":"Lin","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejmech.2025.117906_bib31","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.apsb.2022.10.011","article-title":"G protein-coupled receptor 35 attenuates nonalcoholic steatohepatitis by reprogramming cholesterol homeostasis in hepatocytes","volume":"13","author":"Wei","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.117906_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106690","article-title":"Gpr35 shapes gut microbial ecology to modulate hepatic steatosis","volume":"189","author":"Wu","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2025.117906_bib33","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/hep.31290","article-title":"The L-\u03b1-Lysophosphatidylinositol\/G protein-coupled receptor 55 system induces the development of nonalcoholic steatosis and steatohepatitis","volume":"73","author":"Fondevila","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2025.117906_bib34","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cmet.2024.03.016","article-title":"Loss of GPR75 protects against non-alcoholic fatty liver disease and body fat accumulation","volume":"36","author":"Leeson-Payne","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejmech.2025.117906_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155630","article-title":"Protective effects of the succinate\/SUCNR1 axis on damaged hepatocytes in NAFLD","volume":"145","author":"Marsal-Beltran","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.ejmech.2025.117906_bib36","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jhep.2021.09.032","article-title":"Dopamine receptor D2 antagonism normalizes profibrotic macrophage-endothelial crosstalk in non-alcoholic steatohepatitis","volume":"76","author":"Qing","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejmech.2025.117906_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102187","article-title":"The sex steroid precursor dehydroepiandrosterone prevents nonalcoholic steatohepatitis by activating the AMPK pathway mediated by GPR30","volume":"48","author":"Li","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2025.117906_bib38","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.immuni.2020.08.004","article-title":"Osteopontin expression identifies a subset of recruited macrophages distinct from kupffer cells in the fatty liver","volume":"53","author":"Remmerie","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2025.117906_bib39","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/HEP.0000000000000270","article-title":"Mapping the hepatic immune landscape identifies monocytic macrophages as key drivers of steatohepatitis and cholangiopathy progression","volume":"78","author":"Guillot","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2025.117906_bib40","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1172\/JCI124615","article-title":"The role of macrophages in the resolution of inflammation","volume":"129","author":"Watanabe","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2025.117906_bib41","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/intimm\/dxy054","article-title":"Macrophages in inflammation, repair and regeneration","volume":"30","author":"Oishi","year":"2018","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ejmech.2025.117906_bib42","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00109-023-02325-4","article-title":"Myeloid-specific deletion of chitinase-3-like 1 protein ameliorates murine diet-induced steatohepatitis progression","volume":"101","author":"Kim","year":"2023","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.ejmech.2025.117906_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156114","article-title":"A3AR antagonism mitigates metabolic dysfunction-associated steatotic liver disease by exploiting monocyte-derived Kupffer cell necroptosis and inflammation resolution","volume":"164","author":"Park","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.ejmech.2025.117906_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105561","article-title":"Leukotriene B4 receptor 2 governs macrophage migration during tissue inflammation","volume":"300","author":"Ermis","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117906_bib45","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/gutjnl-2015-310344","article-title":"Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptors","volume":"66","author":"Wieser","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.ejmech.2025.117906_bib46","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1172\/JCI61953","article-title":"G protein-coupled receptor 21 deletion improves insulin sensitivity in diet-induced obese mice","volume":"122","author":"Osborn","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2025.117906_bib47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature01905","article-title":"Proton-sensing G-protein-coupled receptors","volume":"425","author":"Ludwig","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117906_bib48","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s41590-022-01231-0","article-title":"pH sensing controls tissue inflammation by modulating cellular metabolism and endo-lysosomal function of immune cells","volume":"23","author":"Chen","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejmech.2025.117906_bib49","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2257269","article-title":"Intestinal epithelial pH-sensing receptor GPR65 maintains mucosal homeostasis via regulating antimicrobial defense and restrains gut inflammation in inflammatory bowel disease","volume":"15","author":"Li","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.ejmech.2025.117906_bib50","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2410653121","article-title":"Activation of the proton-sensing GPCR, GPR65 on fibroblast-like synoviocytes contributes to inflammatory joint pain","volume":"121","author":"Pattison","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2025.117906_bib51","doi-asserted-by":"crossref","first-page":"45626","DOI":"10.1074\/jbc.M406966200","article-title":"TDAG8 is a proton-sensing and psychosine-sensitive G-protein-coupled receptor","volume":"279","author":"Wang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117906_bib52","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12964-023-01249-3","article-title":"GPR65 inhibits human trophoblast cell adhesion through upregulation of MYLK and downregulation of fibronectin via cAMP-ERK signaling in a low pH environment","volume":"21","author":"Mao","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ejmech.2025.117906_bib53","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fimmu.2016.00222","article-title":"Molecular mechanisms for cAMP-Mediated immunoregulation in T cells - role of anchored protein kinase A signaling units","volume":"7","author":"Wehbi","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.117906_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110294","article-title":"IBD-associated G protein-coupled receptor 65 variant compromises signalling and impairs key functions involved in inflammation","volume":"93","author":"Mercier","year":"2022","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2025.117906_bib55","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1172\/JCI97831","article-title":"G\u03b112 ablation exacerbates liver steatosis and obesity by suppressing USP22\/SIRT1-regulated mitochondrial respiration","volume":"128","author":"Kim","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2025.117906_bib56","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/s12276-020-0454-5","article-title":"G\u03b1(12\/13) signaling in metabolic diseases","volume":"52","author":"Yang","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2025.117906_bib57","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s00011-024-01961-x","article-title":"The role of G\u03b1q in regulating NLRP3 inflammasome activation","volume":"73","author":"Kong","year":"2024","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejmech.2025.117906_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166288","article-title":"GPR65 (TDAG8) inhibits intestinal inflammation and colitis-associated colorectal cancer development in experimental mouse models","volume":"1868","author":"Marie","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.ejmech.2025.117906_bib59","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nsmb.3014","article-title":"PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome","volume":"22","author":"Kroeze","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.117906_bib60","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1038\/s41467-024-54299-7","article-title":"G(12\/13)-mediated signaling stimulates hepatic glucose production and has a major impact on whole body glucose homeostasis","volume":"15","author":"Pittala","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117906_bib61","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.cell.2020.08.024","article-title":"Structure of a hallucinogen-activated Gq-Coupled 5-HT(2A) serotonin receptor","volume":"182","author":"Kim","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.117906_bib62","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1161\/STROKEAHA.124.046954","article-title":"Targeting neuronal GPR65 with delayed BTB09089 treatment improves neurorehabilitation following ischemic stroke","volume":"55","author":"Chen","year":"2024","journal-title":"Stroke"},{"key":"10.1016\/j.ejmech.2025.117906_bib63","doi-asserted-by":"crossref","first-page":"13117","DOI":"10.1073\/pnas.2000430117","article-title":"DCyFIR: a high-throughput CRISPR platform for multiplexed G protein-coupled receptor profiling and ligand discovery","volume":"117","author":"Kapolka","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2025.117906_bib64","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature15699","article-title":"Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65","volume":"527","author":"Huang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117906_bib65","article-title":"In silico and pharmacological evaluation of GPR65 as a cancer immunotherapy target regulating T-cell functions","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.117906_bib66","doi-asserted-by":"crossref","first-page":"9896","DOI":"10.1021\/acs.jmedchem.3c02423","article-title":"Potent, selective agonists for the cannabinoid-like orphan G protein-coupled receptor GPR18: a promising drug target for cancer and immunity","volume":"67","author":"Mahardhika","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117906_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/biom10050686","article-title":"Computational investigations on the binding mode of ligands for the cannabinoid-activated G protein-coupled receptor GPR18","volume":"10","author":"Neumann","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2025.117906_bib68","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1021\/acs.jmedchem.3c01923","article-title":"Structure-activity relationship studies and optimization of 4-Hydroxypyridones as GPR84 agonists","volume":"67","author":"Ieremias","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117906_bib69","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1006\/geno.1997.4752","article-title":"Cloning and chromosomal localization of a gene (GPR18) encoding a novel seven transmembrane receptor highly expressed in spleen and testis","volume":"42","author":"Gantz","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.ejmech.2025.117906_bib70","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.20150225","article-title":"Identification of resolvin D2 receptor mediating resolution of infections and organ protection","volume":"212","author":"Chiang","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejmech.2025.117906_bib71","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13041-018-0351-1","article-title":"Resolvin D2 protects against cerebral ischemia\/reperfusion injury in rats","volume":"11","author":"Zuo","year":"2018","journal-title":"Mol. Brain"},{"key":"10.1016\/j.ejmech.2025.117906_bib72","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1038\/s41467-021-26516-0","article-title":"Resolvin-D2 targets myogenic cells and improves muscle regeneration in Duchenne muscular dystrophy","volume":"12","author":"Dort","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117906_bib73","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202302336RR","article-title":"Resolvin D2 limits atherosclerosis progression via myeloid cell-GPR18","volume":"38","author":"Lipscomb","year":"2024","journal-title":"FASEB J."},{"key":"10.1016\/j.ejmech.2025.117906_bib74","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2025.117906_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11102711","article-title":"The potential role of C-Reactive protein in metabolic-dysfunction-associated fatty liver disease and aging","volume":"11","author":"Ding","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejmech.2025.117906_bib76","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.ajpath.2023.08.011","article-title":"Resolvin D2-G-Protein coupled receptor 18 enhances bone marrow function and limits steatosis and hepatic collagen accumulation in aging","volume":"193","author":"Fitzgerald","year":"2023","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejmech.2025.117906_bib77","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.2147\/DDDT.S329507","article-title":"Activation of GPR18 by resolvin D2 relieves pain and improves bladder function in cyclophosphamide-induced cystitis through inhibiting TRPV1","volume":"15","author":"Lu","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2025.117906_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100679","article-title":"Resolvin D2\/GPR 18 axis ameliorates pressure overload-induced heart failure by inhibiting pro-inflammatory macrophage polarization","volume":"65","author":"Zheng","year":"2024","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejmech.2025.117906_bib79","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jhep.2022.12.031","article-title":"Capsaicin receptor TRPV1 maintains quiescence of hepatic stellate cells in the liver via recruitment of SARM1","volume":"78","author":"Tao","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejmech.2025.117906_bib80","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1111\/j.1476-5381.2011.01497.x","article-title":"\u0394(9) -Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells","volume":"165","author":"McHugh","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117906_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112418","article-title":"Naringin dihydrochalcone alleviates sepsis-induced acute lung injury via improving gut microbial homeostasis and activating GPR18 receptor","volume":"137","author":"He","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2025.117906_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25061384","article-title":"A novel alternative in the treatment of detrusor overactivity? In vivo activity of O-1602, the newly synthesized agonist of GPR55 and GPR18 cannabinoid receptors","volume":"25","author":"Wr\u00f3bel","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117906_bib83","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1021\/acsptsci.4c00356","article-title":"Novel peripherally selective cannabinoid receptor 1 neutral antagonist improves metabolic dysfunction-associated steatotic liver disease in mice","volume":"7","author":"Laudermilk","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ejmech.2025.117906_bib84","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/bs.ai.2017.05.003","article-title":"G protein-coupled receptor kinases in the inflammatory response and signaling","volume":"136","author":"Steury","year":"2017","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.ejmech.2025.117906_bib85","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1021\/acsmedchemlett.0c00208","article-title":"Discovery of tricyclic xanthines as agonists of the cannabinoid-activated orphan G-Protein-Coupled receptor GPR18","volume":"11","author":"Schoeder","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117906_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/ph14080799","article-title":"The GPR18 agonist PSB-KD-107 exerts endothelium-dependent vasorelaxant effects","volume":"14","author":"Kota\u0144ska","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.117906_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1187253","article-title":"Gpr18 agonist dampens inflammation, enhances myogenesis, and restores muscle function in models of Duchenne muscular dystrophy","volume":"11","author":"Dort","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejmech.2025.117906_bib88","article-title":"Novel selective agonist of GPR18, PSB-KK-1415 exerts potent anti-inflammatory and anti-nociceptive activities in animal models of intestinal inflammation and inflammatory pain","volume":"33","author":"Fabisiak","year":"2021","journal-title":"Neuro Gastroenterol. Motil."},{"key":"10.1016\/j.ejmech.2025.117906_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24109046","article-title":"Novel GPR18 ligands in rodent pharmacological tests: effects on mood, pain, and eating disorders","volume":"24","author":"Frankowska","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117906_bib90","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1016\/j.molcel.2021.09.007","article-title":"Intrinsic bias at non-canonical, \u03b2-arrestin-coupled seven transmembrane receptors","volume":"81","author":"Pandey","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2025.117906_bib91","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.4049\/jimmunol.1401989","article-title":"\u03b2-arrestin1 is critical for the full activation of NLRP3 and NLRC4 inflammasomes","volume":"194","author":"Mao","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejmech.2025.117906_bib92","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1053\/j.gastro.2014.03.014","article-title":"Lactate reduces liver and pancreatic injury in toll-like receptor- and inflammasome-mediated inflammation via GPR81-mediated suppression of innate immunity","volume":"146","author":"Hoque","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejmech.2025.117906_bib93","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jhep.2019.12.004","article-title":"ARRB1 inhibits non-alcoholic steatohepatitis progression by promoting GDF15 maturation","volume":"72","author":"Zhang","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejmech.2025.117906_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115804","article-title":"Metoprolol disrupts inflammatory response of human cardiomyocytes via \u03b2-arrestin2 biased agonism and NF-\u03baB signaling modulation","volume":"168","author":"Ricci","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.117906_bib95","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1189\/jlb.69.6.1045","article-title":"Cloning and expression analysis of a novel G-protein-coupled receptor selectively expressed on granulocytes","volume":"69","author":"Yousefi","year":"2001","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejmech.2025.117906_bib96","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1006\/jmbi.2001.4520","article-title":"An expressed sequence tag (EST) data mining strategy succeeding in the discovery of new G-protein coupled receptors","volume":"307","author":"Wittenberger","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.117906_bib97","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/s41401-023-01080-z","article-title":"GPR84 regulates pulmonary inflammation by modulating neutrophil functions","volume":"44","author":"Wang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2025.117906_bib98","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1038\/s41401-021-00825-y","article-title":"GPR84 signaling promotes intestinal mucosal inflammation via enhancing NLRP3 inflammasome activation in macrophages","volume":"43","author":"Zhang","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2025.117906_bib99","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1089\/dna.2020.5846","article-title":"20 years an orphan: is GPR84 a plausible medium-chain fatty acid-sensing receptor?","volume":"39","author":"Luscombe","year":"2020","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.ejmech.2025.117906_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106047","article-title":"Hydroxycarboxylic acid receptor 3 and GPR84 - two metabolite-sensing G protein-coupled receptors with opposing functions in innate immune cells","volume":"176","author":"Peters","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2025.117906_bib101","doi-asserted-by":"crossref","DOI":"10.1172\/JCI168992","article-title":"GPR84-mediated signal transduction affects metabolic function by promoting brown adipocyte activity","volume":"133","author":"Sun","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2025.117906_bib102","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.165469","article-title":"Medium-chain fatty acids suppress lipotoxicity-induced hepatic fibrosis via the immunomodulating receptor GPR84","volume":"8","author":"Ohue-Kitano","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejmech.2025.117906_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105406","article-title":"Fatty acid sensing GPCR (GPR84) signaling safeguards cartilage homeostasis and protects against osteoarthritis","volume":"164","author":"Wang","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2025.117906_bib104","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/gutjnl-2020-323219","article-title":"Decoy bypass for appetite suppression in obese adults: role of synergistic nutrient sensing receptors GPR84 and FFAR4 on colonic endocrine cells","volume":"71","author":"Peiris","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.ejmech.2025.117906_bib105","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1038\/s41467-023-41201-0","article-title":"Pro-phagocytic function and structural basis of GPR84 signaling","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117906_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9041140","article-title":"The medium-chain fatty acid receptor GPR84 mediates myeloid cell infiltration promoting steatohepatitis and fibrosis","volume":"9","author":"Puengel","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejmech.2025.117906_bib107","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics15030342","article-title":"Molecular clustering of metabolic dysfunction-associated steatotic liver disease based on transcriptome analysis","volume":"15","author":"Ryu","year":"2025","journal-title":"Diagnostics"},{"key":"10.1016\/j.ejmech.2025.117906_bib108","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69675-8","article-title":"Fatty acid mimetic PBI-4547 restores metabolic homeostasis via GPR84 in mice with non-alcoholic fatty liver disease","volume":"10","author":"Simard","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117906_bib109","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12964-020-0516-2","article-title":"Natural biased signaling of hydroxycarboxylic acid receptor 3 and G protein-coupled receptor 84","volume":"18","author":"Peters","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ejmech.2025.117906_bib110","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abl4283","article-title":"Migration mediated by the oxysterol receptor GPR183 depends on arrestin coupling but not receptor internalization","volume":"16","author":"Kj\u00e6r","year":"2023","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ejmech.2025.117906_bib111","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1182\/blood-2007-07-102103","article-title":"CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome","volume":"112","author":"Lagane","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2025.117906_bib112","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1021\/acs.jmedchem.3c02375","article-title":"Discovery and characterization of a new class of C5aR1 antagonists showing in vivo activity","volume":"67","author":"Hubler","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117906_bib113","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01794-2022","article-title":"GLPG1205 for idiopathic pulmonary fibrosis: a phase 2 randomised placebo-controlled trial","volume":"61","author":"Strambu","year":"2023","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejmech.2025.117906_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101932","article-title":"Selective phosphorylation of threonine residues defines GPR84-arrestin interactions of biased ligands","volume":"298","author":"Marsango","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117906_bib115","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.phrs.2018.02.021","article-title":"Embelin and its derivatives unravel the signaling, proinflammatory and antiatherogenic properties of GPR84 receptor","volume":"131","author":"Gaidarov","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2025.117906_bib116","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/0960327120934522","article-title":"Embelin modulates metabolic endotoxemia and associated obesity in high fat diet fed C57BL\/6 mice","volume":"40","author":"Bansal","year":"2021","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.ejmech.2025.117906_bib117","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/s44319-024-00092-y","article-title":"XIAP-mediated degradation of IFT88 disrupts HSC cilia to stimulate HSC activation and liver fibrosis","volume":"25","author":"Hong","year":"2024","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ejmech.2025.117906_bib118","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1021\/acschembio.9b00533","article-title":"A biased agonist at immunometabolic receptor GPR84 causes distinct functional effects in macrophages","volume":"14","author":"Lucy","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117906_bib119","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1021\/acs.jmedchem.3c00951","article-title":"Development of highly potent, G-Protein pathway biased, selective, and orally bioavailable GPR84 agonists","volume":"67","author":"Wang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117906_bib120","doi-asserted-by":"crossref","first-page":"11270","DOI":"10.1021\/acs.jmedchem.2c00804","article-title":"Investigating the structure-activity relationship of 1,2,4-Triazine G-Protein-Coupled receptor 84 (GPR84) antagonists","volume":"65","author":"Mahindra","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117906_bib121","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1021\/acs.jmedchem.3c00053","article-title":"Unsymmetrical phosphodiesters as GPR84 antagonists with high blood exposure for the treatment of lung inflammation","volume":"66","author":"Li","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117906_bib122","doi-asserted-by":"crossref","first-page":"10875","DOI":"10.1021\/acs.jmedchem.4c00359","article-title":"Discovery of GPR84 fluorogenic probes based on a novel antagonist for GPR84 bioimaging","volume":"67","author":"Xiao","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117906_bib123","doi-asserted-by":"crossref","first-page":"13526","DOI":"10.1021\/acs.jmedchem.0c00272","article-title":"Discovery of 9-Cyclopropylethynyl-2-((S)-1-[1,4]dioxan-2-ylmethoxy)-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one (GLPG1205), a unique GPR84 negative allosteric modulator undergoing evaluation in a phase II clinical trial","volume":"63","author":"Lab\u00e9gu\u00e8re","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117906_bib124","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1073\/pnas.022460899","article-title":"Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides","volume":"99","author":"Covic","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2025.117906_bib125","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/nm760","article-title":"Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation","volume":"8","author":"Covic","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2025.117906_bib126","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/hep.32589","article-title":"PAR2 promotes impaired glucose uptake and insulin resistance in NAFLD through GLUT2 and Akt interference","volume":"76","author":"Shearer","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2025.117906_bib127","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/gutjnl-2020-323363","article-title":"Activation of the GPR35 pathway drives angiogenesis in the tumour microenvironment","volume":"71","author":"Pagano","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.ejmech.2025.117906_bib128","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aau9048","article-title":"GPR35 promotes glycolysis, proliferation, and oncogenic signaling by engaging with the sodium potassium pump","volume":"12","author":"Schneditz","year":"2019","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ejmech.2025.117906_bib129","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cmet.2021.12.022","article-title":"Autonomous sensing of the insulin peptide by an olfactory G protein-coupled receptor modulates glucose metabolism","volume":"34","author":"Cheng","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejmech.2025.117906_bib130","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1161\/ATVBAHA.120.315168","article-title":"PAR1 (Protease-Activated receptor 1) Pepducin therapy targeting myocardial necrosis in coronary artery disease and acute coronary syndrome patients undergoing cardiac catheterization: a randomized, Placebo-controlled, phase 2 study","volume":"40","author":"Kuliopulos","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejmech.2025.117906_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107242","article-title":"Discovery of a CCR2-targeting pepducin therapy for chronic pain","volume":"205","author":"Midavaine","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2025.117906_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107597","article-title":"A lipidated peptide derived from the C-terminal tail of the vasopressin 2 receptor shows promise as a new \u03b2-arrestin inhibitor","volume":"212","author":"Brouillette","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2025.117906_bib133","doi-asserted-by":"crossref","DOI":"10.3390\/metabo15030178","article-title":"Antagonizing the S1P-S1P3 axis as a promising anti-angiogenic strategy","volume":"15","author":"Avnet","year":"2025","journal-title":"Metabolites"},{"key":"10.1016\/j.ejmech.2025.117906_bib134","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10557-021-07299-4","article-title":"Pepducin ICL1-9-Mediated \u03b22-Adrenergic receptor-dependent cardiomyocyte contractility occurs in a G(i) Protein\/ROCK\/PKD-Sensitive manner","volume":"37","author":"Okyere","year":"2023","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ejmech.2025.117906_bib135","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.010621","article-title":"Suppression of heart failure with PAR1 pepducin technology in a pressure overload model in mice","volume":"16","author":"Fletcher","year":"2023","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.ejmech.2025.117906_bib136","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1124\/jpet.123.001685","article-title":"Blockade of proteinase-activated receptor 2 (PAR2) attenuates neuroinflammation in experimental autoimmune encephalomyelitis","volume":"388","author":"Eftekhari","year":"2024","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2025.117906_bib137","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1161\/ATVBAHA.123.319767","article-title":"PAR4 inhibition reduces coronary artery atherosclerosis and myocardial fibrosis in SR-B1\/LDLR double knockout mice","volume":"43","author":"Lee","year":"2023","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejmech.2025.117906_bib138","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jhep.2024.04.009","article-title":"Targeting EFHD2 inhibits interferon-\u03b3 signaling and ameliorates non-alcoholic steatohepatitis","volume":"81","author":"Fu","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejmech.2025.117906_bib139","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175305","article-title":"The Nr4a family regulates intrahepatic Treg proliferation and liver fibrosis in MASLD models","volume":"134","author":"Aki","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2025.117906_bib140","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1158\/2159-8290.CD-24-0841","article-title":"GPR65 inactivation in tumor cells drives antigen-independent CAR T-cell resistance via macrophage remodeling","volume":"15","author":"Mavuluri","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejmech.2025.117906_bib141","article-title":"Identification and validation of glycolysis-related diagnostic signatures in diabetic nephropathy: a study based on integrative machine learning and single-cell sequence","volume":"15","author":"Wu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.117906_bib142","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1028440","article-title":"Significance of macrophage infiltration in the prognosis of lung adenocarcinoma patients evaluated by scRNA and bulkRNA analysis","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.117906_bib143","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.941556","article-title":"Novel macrophage-related gene prognostic index for glioblastoma associated with M2 macrophages and T cell dysfunction","volume":"13","author":"Ji","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.117906_bib144","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41574-024-00957-1","article-title":"Cryo-electron microscopy for GPCR research and drug discovery in endocrinology and metabolism","volume":"20","author":"Duan","year":"2024","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejmech.2025.117906_bib145","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1016\/j.apsb.2024.06.023","article-title":"Genome-wide pan-GPCR cell libraries accelerate drug discovery","volume":"14","author":"Yang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.117906_bib146","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.cmet.2023.07.010","article-title":"GIPR\/GLP-1R dual agonist therapies for diabetes and weight loss-chemistry, physiology, and clinical applications","volume":"35","author":"Campbell","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejmech.2025.117906_bib147","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1161\/CIRCULATIONAHA.122.059595","article-title":"GLP-1 receptor agonists for the reduction of atherosclerotic cardiovascular risk in patients with type 2 diabetes","volume":"146","author":"Marx","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ejmech.2025.117906_bib148","doi-asserted-by":"crossref","first-page":"eadp5765","DOI":"10.1126\/scitranslmed.adp5765","article-title":"The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron","volume":"16","author":"Sloop","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2025.117906_bib149","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1043828","article-title":"Learn from failures and stay hopeful to GPR40, a GPCR target with robust efficacy, for therapy of metabolic disorders","volume":"13","author":"Guan","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117906_bib150","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1021\/acscentsci.3c01461","article-title":"Flipping the GPCR switch: structure-based development of selective cannabinoid receptor 2 inverse agonists","volume":"10","author":"Kosar","year":"2024","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ejmech.2025.117906_bib151","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1021\/jacsau.3c00503","article-title":"Deep learning dynamic allostery of G-Protein-Coupled receptors","volume":"3","author":"Do","year":"2023","journal-title":"JACS Au"},{"key":"10.1016\/j.ejmech.2025.117906_bib152","doi-asserted-by":"crossref","first-page":"8034","DOI":"10.1021\/acs.jcim.4c00499","article-title":"A multi-angle approach to predict Peptide-GPCR complexes: the N\/OFQ-NOP system as a successful AlphaFold application case study","volume":"64","author":"Ciancetta","year":"2024","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.117906_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102440","article-title":"AI protein structure prediction-based modeling and mutagenesis of a protostome receptor and peptide ligands reveal key residues for their interaction","volume":"298","author":"Guo","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117906_bib154","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn1524","article-title":"AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor 1","volume":"10","author":"D\u00edaz-Holgu\u00edn","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2025.117906_bib155","article-title":"An engineered immunomodulatory IgG1 Fc suppresses autoimmune inflammation through pathways shared with i","volume":"134","author":"Sneed","year":"2024","journal-title":"v. immunoglobulin. J. Clin. Invest."},{"key":"10.1016\/j.ejmech.2025.117906_bib156","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1021\/acs.bioconjchem.3c00120","article-title":"Glycosylation improves the proteolytic stability of exenatide","volume":"34","author":"Chandrashekar","year":"2023","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejmech.2025.117906_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118215","article-title":"Design of potent and proteolytically stable double biaryl-stapled GLP-1R\/GIPR peptide dual agonists","volume":"125","author":"Yang","year":"2025","journal-title":"Bioorg. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425006713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425006713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:00:02Z","timestamp":1776920402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425006713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":157,"alternative-id":["S0223523425006713"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117906","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Orphan GPCRs regulate the metabolic liver diseases through mediating the crosstalk between the liver and immune cells: Mechanisms and therapeutics","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117906","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117906"}}